Professor Karla Arruda and Professor Marcus Maurer discuss the development and implementation of UCARE in Brazil, and its potential benefits for individuals suffering from chronic spontaneous urticaria (CSU). The conversation extends towards exploring the framework of the Brazilian UCARE centres and projects, and how it can be implemented in other countries. Professor Maurer delves into the clinical efficacy, advantages, and impact on patient quality of life of utilising Bruton’s tyrosine kinase inhibitors for the treatment of CSU, along with further discussion of alternative treatments. Access additional resources by signing up to Medthority and to be notified for future ‘All Things Urticaria’ podcast episodes!
Read more news regarding urticaria
Podcast
All Things Urticaria Podcast Episode 61: Bruton’s tyrosine kinase inhibitors in the treatment of CSU
May 9, 2023Professor Karla Arruda and Professor Marcus Maurer discuss the development and implementation of UCARE in Brazil, and its potential benefits for individuals suffering from chronic spontaneous urticaria (CSU). The conversation [...]
News
May 5, 2023Topic: Deep down to the differential diagnosis of urticaria: Autoinflammatory disorders ─ what do we need to know? When: July 12th, 2023, 4:00-5:00 PM CEST Registration: Click here to register [...]
News
May 4, 2023On May 3, the first meeting of all 18 Turkish UCARES took place in Istanbul. This was a great opportunity for our UCARE physicians to present their centers and projects, [...]
